| ²é¿´: 753 | »Ø¸´: 3 | ||
Ý®ÁÖËþľ³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÓÐËÖªµÀ¾«°±ËáÔÚµ°°×ÕýÈ·ÕÛµþ×éװʱÆðµ½µÄ×÷Óã¿£¿£¿
|
ÈçÌâ~ºÜ¶àµ°°×µÄ×é×°ÒºÖж¼º¬Óо«°±ËᣬÓÐËÖªµÀ¾«°±ËáÔÚµ°°×ÕýÈ·ÕÛµþ×éװʱÆðµ½µÄ×÷Óã¿£¿£¿Òª·Ö×Ó²ãÃæµÄ£¬ÊÇÒòΪ¾«°±ËáµÄ³¤²àÁ´ÄÜÆðµ½Ê²Ã´»º³å·ö³ÖµÄ×÷ÓÃô£¿ÎÒÒ²¾ÍÊDz²⣬Çë¸÷λ´óÉñÃǰïÎÒ½â´ðϰ¡£¬²»Òªºê¹ÛµÄ×÷Óã¬ÏëÒª·Ö×Ó²ãÃæµÄ»úÀí~~~£¡£¡£¡Ð»ÁË£¡![]() |
» ²ÂÄãϲ»¶
Áôѧ--²©Ê¿ÕÐÉú
ÒѾÓÐ16È˻ظ´
»¯Ñ§¹¤³Ì£¬±¾211£¬Çóµ÷¼Á£¬abÇø²»ÏÞ
ÒѾÓÐ4È˻ظ´
»¯Ñ§¹¤³Ì¼°¹¤Òµ»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ204È˻ظ´
ºþ±±Ê¦·¶´óѧÕе÷¼ÁÀ²
ÒѾÓÐ9È˻ظ´
ÉÛÑôѧԺʳƷÓ뻯ѧ¹¤³ÌѧԺ˶ʿµ÷¼Á
ÒѾÓÐ0È˻ظ´
Ìì½òÉÌÒµ´óѧ ÉúÎïÓëÒ½Ò©¿ÎÌâ×éÕÐÉú
ÒѾÓÐ0È˻ظ´
ÉúÎﻯ¹¤Ñ§Ë¶ÕÐÊÕµ÷¼Á
ÒѾÓÐ0È˻ظ´
¹ã¶«Ê¯ÓÍ»¯¹¤Ñ§Ôº2026Äê˶ʿÑо¿ÉúÐèÒª¶àÃûÉúÎï£¬ÖÆÒ©¹¤³Ì£¬Ê³Æ·×¨ÒµµÄµ÷¼ÁÉú
ÒѾÓÐ0È˻ظ´
317·Ö Ò»Ö¾Ô¸½ÄÏ´óѧ »¯Ñ§¹¤³Ìѧ˶ Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
»¯¹¤É격
ÒѾÓÐ3È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
´øÓо«°±Ëá¼°ÄòËØµÄ±äÐÔµ°°×ÈçºÎ´¿»¯£¿
ÒѾÓÐ3È˻ظ´
Ý®ÁÖËþ
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 8 (Ó×¶ùÔ°)
- ½ð±Ò: 2661
- É¢½ð: 20
- ºì»¨: 2
- Ìû×Ó: 212
- ÔÚÏß: 62.4Сʱ
- ³æºÅ: 2423107
- ×¢²á: 2013-04-14
- ÐÔ±ð: MM
- רҵ: ÉúÎï´ó·Ö×ӽṹÓ빦ÄÜ
2Â¥2013-10-27 23:15:48
Ý®ÁÖËþ
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 8 (Ó×¶ùÔ°)
- ½ð±Ò: 2661
- É¢½ð: 20
- ºì»¨: 2
- Ìû×Ó: 212
- ÔÚÏß: 62.4Сʱ
- ³æºÅ: 2423107
- ×¢²á: 2013-04-14
- ÐÔ±ð: MM
- רҵ: ÉúÎï´ó·Ö×ӽṹÓ빦ÄÜ
3Â¥2013-10-28 12:08:43
xl_dut
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 13 (СѧÉú)
- ½ð±Ò: 1384.8
- Ìû×Ó: 404
- ÔÚÏß: 156.4Сʱ
- ³æºÅ: 2048813
- ×¢²á: 2012-10-08
- ÐÔ±ð: GG
- רҵ: ΢ÉúÎïÒÅ´«ÓýÖÖѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Ý®ÁÖËþ(kx444555´ú·¢): ½ð±Ò+3, ¹ÄÀø½»Á÷ 2013-10-28 15:04:58
Ý®ÁÖËþ: ½ð±Ò+17, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, лл ~ 2013-10-29 17:05:50
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Ý®ÁÖËþ(kx444555´ú·¢): ½ð±Ò+3, ¹ÄÀø½»Á÷ 2013-10-28 15:04:58
Ý®ÁÖËþ: ½ð±Ò+17, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, лл ~ 2013-10-29 17:05:50
|
½¨ÒéÂ¥Ö÷¿´Ò»ÏÂÕâÆªÎÄÕ£¡ Biotechnol Prog. 2004 Sep-Oct;20(5):1301-8. Role of arginine in protein refolding, solubilization, and purification. Tsumoto K, Umetsu M, Kumagai I, Ejima D, Philo JS, Arakawa T. Source Department of Biomolecular Engineering, Graduate School of Engineering, Tohoku University, Aoba-ku, Sendai 980-8579, Japan. tsumoto@mail.tains.tohoku.ac.jp Abstract Recombinant proteins are often expressed in the form of insoluble inclusion bodies in bacteria. To facilitate refolding of recombinant proteins obtained from inclusion bodies, 0.1 to 1 M arginine is customarily included in solvents used for refolding the proteins by dialysis or dilution. In addition, arginine at higher concentrations, e.g., 0.5-2 M, can be used to extract active, folded proteins from insoluble pellets obtained after lysing Escherichia coli cells. Moreover, arginine increases the yield of proteins secreted to the periplasm, enhances elution of antibodies from Protein-A columns, and stabilizes proteins during storage. All these arginine effects are apparently due to suppression of protein aggregation. Little is known, however, about the mechanism. Various effects of solvent additives on proteins have been attributed to their preferential interaction with the protein, effects on surface tension, or effects on amino acid solubility. The suppression of protein aggregation by arginine cannot be readily explained by either surface tension effects or preferential interactions. In this review we show that interactions between the guanidinium group of arginine and tryptophan side chains may be responsible for suppression of protein aggregation by arginine. |

4Â¥2013-10-28 13:14:38














»Ø¸´´ËÂ¥
ûÈËô£¿¾ÙÀý˵Ã÷Ò²ºÃѽ